House Bill 993 amends Florida law to enhance the informed consent process for patients undergoing assisted reproductive technology (ART) procedures, particularly in vitro fertilization (IVF). The bill requires healthcare providers to obtain informed consent from commissioning couples for each IVF cycle, ensuring they receive detailed information about the procedure, associated risks, and their rights regarding embryo disposition. It introduces a written disposition agreement that outlines future embryo use options, such as storage, transfer, and research donation, while prohibiting the discarding of embryos for nonpayment unless specific conditions are met. Additionally, the bill mandates that healthcare providers disclose reasonable alternatives to ART, success rates, and limits, as well as provide informed consent forms that include options for embryo creation limits and financial responsibilities.

The legislation also emphasizes the importance of clear communication by requiring disclosures to be provided in the patient's primary language and allowing for the use of qualified interpreters. Patients must be allowed to ask questions and can withdraw consent at any time before embryo transfer. The bill establishes guidelines for documenting patients' choices regarding embryo disposition in cases of death, divorce, or nonpayment, and it includes provisions for electronic signatures. Violations of the informed consent requirements will result in disciplinary action against healthcare providers. The provisions of this act are set to take effect on July 1, 2026.

Statutes affected:
H 993 Filed: 742.17